MONDAY, Sept. 28, 2020 (HealthDay News) — Real-world, pre-COVID-19 adverse events data show hydroxychloroquine (HCQ) and chloroquine (CQ) are associated with cardiovascular adverse events (CVAEs), according to a study published online Sept. 22 in the British Journal of Clinical Pharmacology. Adam Goldman, from the Sackler School of Medicine at Tel Aviv University in Israel, and...